HOYA Corporation
HOYA Corporation
- Market cap
- $63.62B
- P/E ratio
- 27.95
Your view on HOCPY
Overview
What the company does, where it operates, and who runs it.
About HOYA Corporation
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Eiichiro Ikeda
- Headquarters
- Nittochi Nishishinjuku Building, Tokyo, JP
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Eiichiro Ikeda
- Headquarters
- Nittochi Nishishinjuku Building, Tokyo, JP
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide.
The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses.
In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources.
Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for HOYA Corporation from FRC's valuation model, read against the market price. HOCPY last traded at $188.18, 28.0× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for HOYA Corporation. Starting points for HOYA Corporation: P/E 28.0, EPS $845.85, beta 0.56 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for HOYA Corporation. HOYA Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for HOYA Corporation. Trailing twelve-month EPS for HOYA Corporation stands at $845.85. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Hold
Analyst ratings
1 rating- Strong Buy0
- Buy0
- Hold1
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | JPY 214.06 | JPY 232.58 | JPY 843.91 | JPY 968.82 |
| Lowest estimate | JPY 199.93 | JPY 217.22 | JPY 839.12 | JPY 957.68 |
| Highest estimate | JPY 222.13 | JPY 241.35 | JPY 850.29 | JPY 981.54 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | JPY 1.751 | JPY 1.031 | JPY 789.311 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | JPY 269.60B | JPY 267.54B | JPY 1.05T | JPY 1.15T |
| Lowest estimate | JPY 262.95B | JPY 246.92B | JPY 1.03T | JPY 1.13T |
| Highest estimate | JPY 274.98B | JPY 277.74B | JPY 1.08T | JPY 1.18T |
| Number of analysts | 10 | 10 | 9 | 10 |
| A year ago | JPY 249.14B | JPY 252.69B | JPY 1.00T | — |
| Growth vs a year ago | +8.2% | +5.9% | +4.6% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for HOYA Corporation. HOYA Corporation has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ALCAlcon Inc. | Healthcare | Medical - Specialties | $36.2B | ||
| BLCOBausch + Lomb Corporation | Healthcare | Medical - Instruments & Supplies | $7.5B | ||
| COOThe Cooper Companies, Inc. | Healthcare | Medical - Instruments & Supplies | $11.6B | ||
| CZMWYCarl Zeiss Meditec AG | Healthcare | Medical - Instruments & Supplies | $2.7B | ||
| ESLOYEssilorLuxottica S.A. | Healthcare | Medical - Instruments & Supplies | $129.8B | ||
| OCPNFOlympus Corporation | Healthcare | Medical - Devices | $10.6B | ||
| SGHTSight Sciences, Inc. | Healthcare | Medical - Devices | $598.6M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| MHUAFMeihua International Medical Technologies Co., Ltd. | Healthcare | OTC | $5.8M | ||
| MLSSMilestone Scientific Inc. | Healthcare | AMEX | $23.3M | ||
| MMSIMerit Medical Systems, Inc. | Healthcare | NASDAQ | $5.1B | ||
| NAN.AXNanosonics Limited | Healthcare | ASX | — | ||
| NEPHNephros, Inc. | Healthcare | NASDAQ | $31.4M | ||
| NNCSFNanosonics Limited | Healthcare | OTC | $697.7M | ||
| NNNNAnbio Biotechnology Class A Ordinary Shares | Healthcare | NASDAQ | $158.0M | ||
| NPRRFNipro Corporation | Healthcare | OTC | $1.3B | ||
| NVSTEnvista Holdings Corp | Healthcare | NYSE | $3.8B | ||
| NXGLNEXGEL, Inc. | Healthcare | NASDAQ | $1.9M | ||
| NXGLWNEXGEL, Inc. | Healthcare | NASDAQ | $581,579 | ||
| OJSYOJsys, Inc. | Healthcare | OTC | $454,285 | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| APIEActivePassive International Equity ETF | $1.1B in assets | 0.28% | |
| BDYNiShares Dynamic Equity Active ETF | $3.0B in assets | 0.04% | |
| SPWOSP Funds S&P World (ex-US) ETF | $244M in assets | 0.28% | |
Largest holders first, then the funds most concentrated in HOCPY.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold HOYA Corporation, and how their positions are changing. At a $63.62B market value, institutional positions materially move HOYA Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming HOYA Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for HOYA Corporation. Coverage tracks HOYA Corporation within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of HOYA Corporation.